Abstract:
A method for treating or preventing an elevated blood lipid level-related diseases such as hyperlipidemia, arteriosclerosis, angina pectoris, stroke and hepatic diseases in a mammal, which comprises administering thereto an effective amount of tannin, gallic acid or ellagic acid.
Abstract:
What is disclosed are food compositions for human consumption wherein polysiloxanes are substituted for all or part of the organic fats and oils in the food. An example of such a food composition is a blueberry muffin prepared by substituting a polyorganosiloxane having the formula (CH.sub.3).sub.3 SiO{(CH.sub.3).sub.2 SiO}.sub.b Si(CH).sub.3 for the fats and oils in the blueberry muffin batter mix.
Abstract:
A norbixin complex with a water-soluble or water-dispersible branched-chain or cyclic polysaccharide or a water-soluble or water-dispersible protein, which will not precipitate upon standing in water, which gives an essentially stable bright reddish or magenta solution in water, and from which complex norbixin cannot be removed by centrifugation, as well as a process for preparing such a complex of norbixin and a substrate, selected from a water-soluble or water-dispersible branched-chain or cyclic polysaccharide and a water-soluble or water-dispersible protein, by contacting the substrate and norbixin in an aqueous solution at an alkaline pH, e.g., above about 8.5, at which pH the norbixin is present in its water-soluble orange alkaline form, and then acidifying to drop the pH to below about 7.7, preferably below about 6.8, thereby complexing the norbixin in its neutral to acidic reddish or magenta form with the substrate, are disclosed.
Abstract:
A process is disclosed for preparing a random copolymer which consists essentially of a copolymer of (i) acrylic acid or methacrylic acid (together "(meth)acrylic"), (ii) acrylamide or methacrylamide (together "(meth)acrylamide"), and (iii) an alkoxyalkyl (meth)acrylate ester ("AAE") present in specified relative proportions. The copolymer is made in alcohol or a mixture of alcohol and water in the presence of an effective amount of initiator, without making a homopolymer or copolymer which is insoluble in water. The random copolymer need not be, and is not separated from the polymerization reaction mixture which is soluble in water, and is surprisingly effective in the treatment of industrial process water used in recirculating water systems, particularly with respect to inhibiting the deposition of calcium phosphate on surfaces of equipment used in such systems.
Abstract:
Copolymers which are substantially completely soluble in water at the low concentration in which they are used to treat process water, include copolymers of acrylic acid ("AA") or methacrylic acid ("MAA") and salts thereof (together referred to herein as "(meth)acrylic acid", and for brevity as "(M)AA"), and a lower alkenyl carboxylate ("LAC") such as vinyl acetate or propionate, optionally together with a salt of a lower alkenyl sulfonate ("SLAS"). Typical copolymers are those of (M)AA and vinyl acetate ("VOAc") present in a molar ratio in the range from 95:5 to about 60:40; and those of (M)AA, VOAc and sodium vinyl sulfonate ("SVS") in a molar ratio in the range from 95:4.9:0.1 to about 50:25:25. If desired, the foregoing copolymers may be hydrolyzed for use as their hydrolyzates, or the copolymers may be at least partially hydrolyzed, prior to or, during use as for example when used in alkaline boiler water systems. The compositions are useful to inhibit the deposition of particulate matter in mud suspended in the process water, and also of scale due to salts dissolved in various process water streams, particularly in boiler water and cooling water. The compositions are therefore not only excellent dispersants but also exhibit unexpected threshold and sequestering effects. They are conventionally formed and have a relatively low molecular weight, preferably in the range from about 1000 to about 25,000. The molar ratio of the reactants is such that (M)AA is always present in a molar amount which is at least 50 mole percent relative to the remaining constituent(s) of the copolymer.
Abstract:
A PROTEIN-MODIFIED SKIM MILK PRODUCT WICH CAN BIND 4 TO 5 TIMES AS MUCH, AND MORE, WATER AS UNMODIFIED SKIM MILK, IS PREPARED BY ADMIXING 1 TO 30 PARTS BY WEIGHT OF CONDENSED SKIM MILK SOLIDS WITH ONE PART OF LACTALBUMIN OR LACTALBUMIN PHOSPHATE OR A MIXTURE THEREOF AN UP TO 2.5% OF A REDUCTING AGENT, ON TOTAL SOLIDS BASIC; HEATING THE MIXTURE AT 140*F. TO 220*F. TO DEVELOP COMPLEXES; ADDING ENOUGH ALKALI TO RAISE PH OF THE MIXTURE WITHIN THE RANGE OF FROM 7.5 TO 9.5 WHILE MAINTAINING THE MIXTURE AT 130*F. TO A 150*F. FOR A PERIOD SUFFICIENT TO REHYDRATE THE COMPLEXES AND SPRAY-DYING THE MIXTURE TO FORM A FREE-FLOWING POWDER PRODUCT.
Abstract:
The present disclosure provides a composition comprising Bifidobacterium lactis and human milk oligosaccharides (HMOs) and use thereof. The composition is capable of effectively enhancing resistance of an organism to Staphylococcus aureus infection, improving innate immunity of an organism, and/or anti-aging, and can be added to various health foods and healthcare foods.
Abstract:
The present invention relates to a method of producing a fermented milk product comprising adding lactic acid bacteria to milk, wherein the bacteria comprise Lactobacillus casei and at least one further strain of lactic acid bacteria of a species other than Lactobacillus casei, wherein the further strain has a deficiency in lactose metabolism but is capable of metabolizing one or several carbohydrates other than lactose present in the milk.
Abstract:
Provided is a composition that may be used for a specific use application, such as a composition for enhancing a breast milk component. A composition containing a bacterium of the genus Bifidobacterium as an active ingredient is described.